Article Sidebar

Submitted
11 October 2018
Accepted
11 October 2018
Published
12 October 2018
Download
PDF
Statistic
Read Counter : 790 Download : 823

Main Article Content

Abstract

The present study aimed to determine the potency of erythropoietin as angiogenesis inducer in ischemic stroke rats model. Animal model was treated by right unilateral common carotid artery occlusion (rUCCAO) for 90 minutes. The stroke model produced decreased motor function. Eight to 12 week-old Wistar rats were used. rHuEPO was administered for 7 days, starting at 24 hours after stroke induction. Motor functions were measured before and 1, 3 and 7 days after rUCCAO. Whereas, histological damage and VEGF expression were evaluated at day 14. The results showed that rHuEPO significantly increased motor function on day 7, reduced the number of damaged body cell and increased VEGF expression in the thalamus area on day 14. As a conclusion, rHuEPO may restore the motoric function and prevent brain neuronal death by inducing angiogenesis through the increase in the expression of VEGF in rUCCAO-induced ischemic stroke model.

Keywords

rHuEPO ischemic stroke motor function angiogenesis VEGF

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Lina, R. N., Rahmadi, M., & Khotib, J. (2018). Erythropoietin Restores Motor Functions through Angiogenesis in the Thalamus Area of Ischemic Stroke in Rats. Folia Medica Indonesiana, 54(3), 189–194. https://doi.org/10.20473/fmi.v54i3.10011
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Bruno A, Kaelin DL, Yilmaz EY (2000). The Subacute Stroke Patient: hours 6 to 72 after stroke onset. In Cohen SN. Management of Ischemic Stroke. New York, McGraw-Hill, p 53-87
  2. Deb P, Sharma S, Hassan KM (2009). Pathophy-siologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17, 197-218
  3. Gandin C, Widman C, Lazdunski M, et al (2016). MLC901 favors angiogenesis and associated reco-very after ischemic stroke in mice. Cerebrovascular Disease 42,139-154
  4. Gonzalez RG, Hirsch JA, Lev MH et al (2011). Acute ischemic stroke. London New York, Springer Heidel-berg Dordrecht
  5. Hacke W, Kaste M, Bogousslavsky J, et al (2003). Ischemic stroke prophylaxis and treatment. European Stroke Initiative Recommendations
  6. Hellewell SC, Yan EB, Alwis DS, et al (2013). Erythro-poietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. Journal of Neuroinflammation 10, 156
  7. Hoke, A. 2006. Erythropoietin and The Nervous System. John Hopkins University, Springer, p 25-101
  8. Hua Y, Schallert T, Keep RF, et al (2002). Behavioral Tests After Intracerebral Hemorrhage in the Rat. Stroke 33, 2478-2484
  9. Jin R, Yang G, Li G (2010). Inflammatory Mechanisms in Ischemic Stroke: Role of Inflammatory Cells. Journal of Leucocyte Biology 87
  10. Ovbiagele B, Huynh MN (2011). Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy. The American Society for Experimental NeuroTherapeutics 8, 319-329
  11. Park SY, Marasini S, Kim GH, et al (2014). A Method for Generate a Mouse Model of Stroke. Experimental Neurobiology 23 (1), 104-114
  12. Pun PB, Lu J, Moochhala S (2009). Involvement of ROS in BBB dysfunction. Free Radical Research 43, 348-364
  13. Rabie T, Marti HH (2008). Brain Protection by Erythro-poietin: A Manifold Task. Physiology 23, 263-274
  14. Ribatti D, Vacca A, Roccaro AM, et al (2003). Erythro-poietin as an angiogenic factor. European Journal of Clinical Investigation, 891-896
  15. Siren AL, Fratelli M, Brines M, et al (2001). Erythro-poietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proceedings of the National Academy of Sciences USA 98, 4044-4049
  16. Vikman, P, Ansar S, Henriksson M, et al (2007). Cere-bral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Experimental Brain Research 183, 499- 510
  17. Wang L, Chopp M, Gregg SR, et al (2008). Neural pro-genitor cells treated with EPO induce angiogenesis through the production of VEGF. Journal of Cerebral Blood Flow and Metabolism 28, 1361-1368
  18. Wang L, Zhang Z, Wang Y, et al (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737

Most read articles by the same author(s)